Diffuse connective tissue diseases (DCTD) represent an heterogeneous group of disorders characterized by systemic inflammatory reactions that are currently classified on clinical grounds. Their aetiopathogenesis is largely unknown and appears to be very complex, associating exogenous factors with an immunogenetic predisposition. In the last decade, studies on human leukocyte antigen (HLA)-disease associations and antinuclear antibodies have provided some useful clues for the diagnosis and clinical management of DCTD.
- Antinuclear antibodies
- Diffuse connective tissue diseases
- Human leukocyte antigens (HLA)
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health